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Antigen presentation: Coming out gracefully
Paul J. Lehner and John Trowsdale
Efficient assembly of antigen-presenting class I MHC
molecules requires the formation of a complex
between the class I molecule and the TAP peptide
transporter. The complex has been found to contain an
additional four proteins, which help to ensure optimal
peptide loading onto the class I molecules.
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Class I molecules of the major histocompatibility complex
(MHC) bind peptides from proteins synthesised
intracellularly and present them to T cells of the type that
bear the CD8 coreceptor. The peptides are derived from
cytosolic proteins degraded by the proteasome and other
less well characterised cytoplasmic and endoplasmic
reticulum (ER) proteinases. Peptide fragments are
translocated into the lumen of the endoplasmic reticulum
by the heterodimeric TAP transporter and loaded onto
newly synthesized MHC class I molecules. The class I
heterotrimer consists of an MHC-encoded heavy chain,
β2-microglobulin and peptide. In the absence of peptide,
class I molecules are very unstable. The importance of
peptide for the structural integrity of class I molecules was
appreciated as soon as class I glycoproteins were
crystallised. However, the ease of folding class I heavy
chain, β2-microglobulin and peptide in vitro belied the
complexity of class I loading in vivo. 
The intricacy of peptide loading and class I assembly
became apparent when it was found that a TAP–class I
complex is formed in the ER [1–3]. Although peptide
binding triggers release of the folded class I molecule from
this complex, it remains unclear how peptide translocation
is coordinated with class I assembly and release from the
TAP complex. Work in several laboratories has now
identified a further four proteins that appear to be associ-
ated with the TAP–class I complex and so to be involved
in class I assembly [3–7]. The minimal components of the
TAP–class I complex now include TAP1 and TAP2, the
class I heavy chain, β2-microglobulin, calnexin, calretic-
ulin, tapasin and  the ERp57 protein, an ER resident chap-
erone with thiol-reductase activity. The role of these addi-
tional proteins in class I presentation is just beginning to
be elucidated, and may reflect the unique problems asso-
ciated with the assembly of a class I molecule with a vari-
able peptide component.
The problem of how individual class I molecules accom-
modate peptides with highly variable sequences has been
solved by structural studies. Appropriate peptides are usu-
ally 8–10 amino acids in length, with anchor residues
which fit into pockets in the class I structure. Class I pep-
tide ligands can differ at most positions as long as some
‘anchor’ residues are conserved — the products of differ-
ent class I alleles requiring different anchor residues. The
principle for selection of peptides by class I appears to be
that of ‘trial and error’. Class I molecules may not adopt
their final, mature conformation until they meet a suitable
peptide, in most cases meaning one with the appropriate
anchor residues. Peptide-free class I molecules, or class I
molecules with loosely-bound peptide, must not be
allowed to escape to the cell surface in large numbers, as
they could pick up fragments of proteins outside the cell.
Precise quality control mechanisms are therefore neces-
sary. This helps to explain the need for additional proteins
in the TAP–class I complex.
The assembly of class I molecules is initiated in the ER,
where nascent, unfolded class I molecules associate with
the resident chaperone calnexin. Calnexin, a non-glycosy-
lated 65 kDa type I membrane protein, and calreticulin, its
46 kDa soluble homologue, are both lectins expressed pre-
dominantly in the ER. Both proteins transiently interact
with monoglucosylated N-linked glycans and promote
folding, assembly and quality control of newly synthesized
glycoproteins. Calnexin is not obligatory for class I assem-
bly: in a calnexin-negative cell line, peptide loading,
assembly and function of class I molecules appear to be
normal [8,9]. In human cells, class I binding to β2-
microglobulin is thought to cause dissociation of calnexin. 
The situation is different in the mouse, where class I heavy
chain–β2-microglobulin dimers interact with calnexin [10]
(also observed with the products of some human MHC
alleles [11]). These species differences probably reflect
differences in N-glycosylation between human and mouse
class I alleles [12]. The class I–β2-microglobulin protein
complex then associates with TAP and forms part of a larg-
er ER complex. Although the precise order of events gov-
erning the assembly of class I molecules within this com-
plex is not yet understood, studies on mutant cell lines
have been useful in determining how the complex might
fit together. 
The existence in TAP-negative cells of a ‘pre-TAP’ com-
plex consisting of a class I heavy chain, β2-microglobulin,
calreticulin, tapasin and ERp57 shows that recruitment
and assembly of these proteins can precede TAP binding
[6,7]. How the components of this pre-TAP complex
assemble is not clear, and results from different laborato-
ries conflict. Tapasin is a 48 kDa, MHC-encoded, type I
transmembrane protein [13,14]. Like TAP1, TAP2 and
MHC class I molecules, tapasin is γ-interferon-inducible,
and like the class I heavy chains it is a member of the
immunoglobulin superfamily. Analysis of a tapasin-nega-
tive mutant cell line provided evidence that tapasin
bridges class I and TAP proteins and plays a critical role in
class I assembly, as in its absence cell-surface MHC class I
levels are decreased [13,15]. Tapasin expression also
increases TAP1 and TAP2 levels and allows more peptide
to be translocated into the ER [16]. 
Hughes and Cresswell [7] found that, in the absence of
tapasin, neither ERp57 nor calreticulin associates with
class I molecules, suggesting that tapasin binding to class I
precedes, or occurs simultaneously with, association with
calreticulin and ERp57. In the same tapasin-negative cell
line, however, Lindquist et al. [6] observed ERp57 in
association with free class I heavy chains, suggesting that
binding of ERp57 occurs shortly after heavy chain synthe-
sis. These conflicting data may reflect the different anti-
bodies and different techniques used for detection.
ERp57 is a 57 kDa, ER-resident protein, synonyms for
which include GRP58, EPp61, Q2, HIP-70 and CPT. The
role of ERp57 in class I assembly can only be speculated on
at present. Like calnexin and calreticulin, ERp57 binds
newly synthesized ER glycoproteins after their N-linked
glycans have been trimmed by glucosidase I and II, and it
has therefore been suggested to act as an ER molecular
chaperone [17,18]. A requirement for multiple chaperones
to interact sequentially or simultaneously with the
TAP–class I complex is not surprising; a similar require-
ment has been reported for other glycoproteins [19]. The
amino-acid sequence of ERp57 shows similarities to pro-
tein disulphide isomerases and the protein has been shown
to make and break disulphide bonds in vitro. This activity
may be used in the oxidation of class I or tapasin molecules,
or, more intriguingly, an oxidative event may be required
to facilitate peptide loading onto class I molecules.
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Possible steps in the assembly of peptide-presenting class I mole-
cules. (1) Class I heavy chains are synthesised and translocated into
the ER lumen. (2) Calnexin binds. (3) ERp57 binds either at this  step
or the following one. (4) Calreticulin replaces calnexin, and β2-
microglobulin binds. (5) Assembly of the peptide-receptive complex of
class I heavy chain, β2-microglobulin, calreticulin, tapasin and ERp57;
this complex may exist independently of TAP (see text). (6) TAP asso-
ciation and binding of appropriate peptide (triangles). (7) Release of
mature, peptide-binding class I complex.
Hughes and Cresswell [7] found that ERp57 associates
with TAP only in the presence of tapasin and β2-
microglobulin. Lindquist et al. [6] observed ERp57 in
association with class I heavy chains before binding to β2-
microglobulin. Both sets of results are consistent with a
possible role for ERp57 in the oxidation of class I mole-
cules, though those of Lindquist et al. [6] suggest action
earlier in the assembly pathway than is indicated by those
of Hughes and Cresswell [7]. Both oxidised and reduced
class I heavy chains are associated with calnexin, whereas
calreticulin binds only to oxidised, β2-microglobulin-asso-
ciated class I heavy chains, again supporting a role for
disulphide isomerase activity early in the assembly path-
way [20,21]. Furthermore, the disulphide isomerase
action of ERp57 is more efficient when associated with
calnexin or calreticulin [22]. In vitro, ERp57 has also been
shown to have cysteine protease activity and may be
involved in the ER trimming of longer TAP-translocated
peptides [23,24].
The stoichiometry of the TAP complex suggests that
tapasin and class I are present in a one-to-one ratio, and up
to four tapasin or class I molecules are able to associate
with a single TAP heterodimer [13]. The number of cal-
nexin, calreticulin and ERp57 molecules in this final
TAP–class I complex has not yet been determined.
Translocation and binding of a peptide to a complex with
an appropriate class I heavy chain causes release of the
folded class I molecule and subsequent transport of the
class I–peptide complex to the cell surface. This assembly
pathway for class I molecules is summarized in Figure 1.
Quality control of newly assembled class I heterotrimers
not only requires correct folding of class I molecules, but
must also ensure that ‘optimal’ peptides are bound and can
be presented to T cells. Suboptimal peptides that dissoci-
ate quickly from the complex — have fast ‘off rates’ —
should be preferentially replaced with peptides that have
slow off rates. Sijts and Pamer [25] have suggested that the
ER provides an environment which allows peptides with
fast off rates to dissociate more readily, allowing those with
slow off rates to bind preferentially to the class I molecules
and be presented at the cell surface. 
Tapasin was recently suggested to have a specific pep-
tide-editing function [16]. Recombinant soluble tapasin
fails to bind TAP, but can bind to class I molecules; sur-
prisingly, soluble tapasin can still promote peptide loading
onto class I molecules, and restores surface expression of
MHC class I as effectively as wild-type tapasin. These
findings suggest that tapasin facilitates peptide binding
and assembly of class I molecules independently of its
association with TAP. Whether tapasin promotes class I
assembly by a specific ‘foldase’ activity, by prolonging the
half-life of class I [26], or through a peptide-editing func-
tion has not been determined. 
Studies on mutant class I molecules have provided further
evidence for ‘quality control’ of class I maturation in the
ER. Lewis and Elliott [27] have studied a variant of a
particular human class I molecule, HLA-A*0201 with a
threonine-for-lysine substitution at residue 134, which was
earlier reported not to co-immunoprecipitate with TAP
molecules. The mutant molecule also fails to bind to cal-
reticulin; whether it interacts with tapasin was not reported.
Interestingly, the data are interpreted to show that T134K
molecules are released from the ER in a TAP-dependent
manner. In other words, TAP-delivered peptide is needed
to release the mutant heavy chains, even though they
escape as peptide-receptive (empty) molecules. 
Lewis and Elliott [27] suggest from these findings that
class I MHC maturation takes place in two stages. Initial
binding of suboptimal peptides may occur in the first
stage, but normally class I molecules are not allowed to
leave the ER until an optimal peptide is bound. This sec-
ond phase of quality control would ensure that optimal
peptides with slow off rates are presented at the cell sur-
face. Other interpretations of the data cannot be eliminat-
ed, including the possibility that changing the amino acid
at position 134 alters the conformation of the molecule in
some unpredictable way. In summary, both class-I-dedi-
cated proteins and more general molecular chaperones are
involved in the assembly of peptide-presenting class I mol-
ecules. The role of these proteins in class I folding and
quality control of peptide loading in the ER is beginning
to be unravelled
Acknowledgements
We thank Peter Cresswell and Jonathan Lindquist for helpful discussions, as
well as Jonathan Lindquist for help in devising Figure 1.
References
1. Ortmann B, Androlewicz M, Cresswell P: MHC class I/b2-
microglobulin complexes associate with TAP transporters before
peptide binding. Nature 1994, 368:864-867.
2. Suh W, Cohen-Doyle MF, Froh K, Wang K, Peterson PA, Williams
DB: Interaction of MHC class I molecules with the transporter
associated with antigen processing. Science 1994, 
264:1322-1326.
3. Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P: Roles for
calreticulin and a novel glycoprotein, tapasin, in the interaction of
MHC class I molecules with TAP. Immunity 1996, 5:103-114.
4. Morrice NA, Powis SJ: Role for ERp57 in the assembly of MHC
class I molecules. Curr Biol 1998, 8:713-716.
5. Suh WK, Mitchell EK, Yang Y, Peterson PA, Williams DB: MHC class
I molecules form ternary complexes with calnexin and TAP and
undergo peptide-regulated interaction with TAP via their extracel-
lular domains. J Exp Med 1996, 184:337-348.
6. Lindquist JA, Jensen ON, Mann M, Hammerling GJ: ER-60, a chaper-
one with thiol-dependent reductase activity involved in MHC
class I assembly. EMBO J 1998, 17:2186-2195.
7. Hughes EA, Cresswell P: A thiol oxidoreductase (ERp57) is a com-
ponent of the MHC class I peptide loading complex. Curr Biol
1998, 8:709-712.
8. Sadasivan BK, Cariappa A, Waneck GL, Cresswell P: Assembly,
peptide loading, and transport of MHC class I molecules in a cal-
nexin-negative cell line. Cold Spring Harbor Symp Quant Biol
1995, LV:267-275.
9. Scott JE, Dawson JR: MHC class I expression and transport in a
calnexin-deficient cell line. J Immunol 1995, 155:143-148.
Dispatch R607
10. Degen E, Cohen-Doyle MF, Williams DB: Efficient dissociation of
the p88 chaperone from major histocompatibility complex class I
molecules requires both b2-microglobulin and peptide. J Exp
Med 1992, 175:1653-1661.
11. Carreno BM, Solheim JC, Harris M, Stroynowski I, Connolly JM,
Hansen TH: TAP associates with a unique class I conformation,
whereas calnexin associates with multiple class I forms in
mouse and man. J Immunol 1995, 155:4726-4733.
12. Zhang Q, Salter RD: Distinct patterns of folding and interactions
with calnexin and calreticulin in human class I MHC proteins with
altered N-glycosylation. J Immunol 1998, 160:831-837.
13. Ortmann B, Copeman J, Lehner PJ, Sadasivan B, Herbert JA,
Grandea AG, Riddell SR, Tampe R, Spies T, Trowsdale J, Cresswell
P: A critical role for tapasin in the assembly and function of mul-
timeric MHC class I-TAP complexes. Science 1997, 
277:1306-1309.
14. Li S, Sjogren H, Hellman U, Pettersson RF, Wang P: Cloning and
functional characterization of a subunit of the transporter associ-
ated with antigen processing. Proc Natl Acad Sci USA 1997,
94:8708-8713.
15. Grandea AG, Androlewicz MJ, Athwal RS, Geraghty DE, Spies T:
Dependence of peptide binding by MHC class I molecules on
their interaction with TAP. Science 1995, 270:105.
16. Lehner PJ, Surman MJ, Cresswell P: Soluble tapasin restores MHC
class I expression and function in the tapasin-negative cell line
.220. Immunity 1998, 8:221-231.
17. Oliver JD, van der Wal FJ, Bulleid NJ, High S: Interaction of the
thiol-dependent reductase ERp57 with nascent glycoproteins.
Science 1997, 275:86-88.
18. Hirano N, Shibasaki F, Sakai R, Tanaka T, Nishida J, Yazaki Y,
Takenawa T, Hirai H: Molecular cloning of the human glucose-reg-
ulated protein ERp57/GRP58, a thiol-dependent reductase.
Identification of its secretory form and inducible expression by
the oncogenic transformation. Eur J Biochem 1995, 234:336-342.
19. Helenius A, Sergio Trombetta E, Hebert DN, Simons JF: Calnexin,
calreticulin and the folding of glycoproteins. Trends Cell Biol
1997, 7:193-200.
20. Ribaudo RK, Margulies DH: Independent and synergistic effects of
disulphide bond formation, b2M, and peptides on class I MHC
folding and assembly in an in vitro translation system. J Immunol
1992, 149:2935-2944.
21. Tector M, Zhang Q, Salter RD: b2-Microglobulin and calnexin can
independently promote folding and disulphide bond formation in
class I histocompatibility proteins. Mol Imm 1997, 34:401-408.
22. Zapun A, Darby NJ, Tessier DC, Michalak M, Bergeron JJM, Thomas
DY: Enhanced catalysis of ribonuclease B folding by the interac-
tion of calnexin or calreticulin with ERp57. J Biol Chem 1998,
273:6009-6012.
23. Roelse J, Gromme M, Momburg F, Hammerling G, Neefjes J:
Trimming of TAP- translocated peptides in the ER and in the
cytosol during recycling. J Exp Med 1994, 180:1591-1597. 
24. Elliott T, Willis A, Cerundolo V, Towsend A: Processing of MHC
class I-restricted antigens in the endoplasmic reticulum. J Exp
Med 1995, 181:1481-1491. 
25. Sijts AJA, Pamer EG: Enhanced intracellular dissociation of major
histocompatibility complex class I-associated peptides: a mecha-
nism for optimizing the spectrum of cell surface-presented cyto-
toxic T lymphocyte epitopes. J Exp Med 1997, 185:1403-1411.
26. Grandea G III, Lehner PJ, Cresswell P, Spies T: Regulation of MHC
class I heterodimer stability and interaction with TAP by tapasin.
Immunogenetics 1997, 46:477-483.
27. Lewis JW, Elliott T: Evidence for successive peptide binding and
quality control stages during class I MHC assembly. Curr Biol
1998, 8:717-720.
R608 Current Biology, Vol 8 No 17
